Margarita Pallares
Acute Care · South Miami, FLNPI 1215484704
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $33.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$823
- Daiichi Sankyo Inc.$657
- Amgen$568
- AstraZeneca$553
- Bayer$478
- Lexicon Pharmaceuticals, Inc.$244
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,56198%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 21 | $823 |
| Daiichi Sankyo Inc. | 28 | $657 |
| Amgen | 21 | $568 |
| AstraZeneca | 10 | $553 |
| Bayer | 10 | $478 |
| Lexicon Pharmaceuticals, Inc. | 2 | $244 |
| AbbVie | 8 | $180 |
| Pfizer | 8 | $175 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $167 |
| E.r. Squibb & Sons, L.L.C. | 3 | $162 |
| Heartflow, Inc. | 1 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
| United Therapeutics Corporation | 4 | $71 |
| Impulse Dynamics (USA) Inc. | 4 | $64 |
| Abbott | 2 | $45 |
| Kestra Medical Technology Services, Inc. | 2 | $40 |
| Novartis | 2 | $36 |
| Lundbeck LLC | 1 | $26 |
| GSK | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,650 in reported general payments places this provider in the 90th percentile of 1,150 acute care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 23 | $1,887 |
| Warfarin Sodium | 126 | $773 |
| JantovenWarfarin Sodium | 50 | $279 |
| Bumetanide | 12 | $250 |
Paid to pharmacies, not to this prescriber.
Other acute care in South Miami
- Ailin Sierra HernandezSouth Miami$5K
- Adryanna RuizSouth Miami$5K
- Melisa WilsonOrlando$214K
- Amanda PeacockJacksonville$81K
- Katrina RileyTampa$66K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melanie WeresJacksonville$37K
- Jayne JaramilloJacksonville$27K
- Melissa HamiltonTampa$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.